Oncolytics Biotech Inc. (ONCY) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Oncolytics Biotech Inc. (ONCY).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $0.946

Daily Change: +$0.0156 / 1.65%

Daily Range: $0.88 - $0.989

Market Cap: $89,718,144

Daily Volume: 548,200

Performance Metrics

1 Week: -10.28%

1 Month: -23.74%

3 Months: 76.63%

6 Months: 23.56%

1 Year: -6.00%

YTD: 0.14%

Company Details

Employees: 28

Sector: Health technology

Industry: Biotechnology

Country:

Details

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in Calgary, Canada.

Selected stocks

180 Degree Capital Corp. (TURN)

Lazydays Holdings, Inc. (GORV)

Cryo-Cell International, Inc. (CCEL)